Before you sell to, join or invest in Amptiv Biosciences, Inc.
MentionFox check on Amptiv Biosciences, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/amptiv-biosciences-inc-form-d-25000001
Check Amptiv Biosciences, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Amptiv Biosciences, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Amptiv Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2025-04-04.
Amptiv Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 4, 2025. The filing reports $300K sold. Its industry group is Other Health Care. It names Jonathan Bell (Executive Officer, Director), Jon Armstrong (Director) (SEC Form D, April 4, 2025).
Is this your company?
Sell to companies like Amptiv Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-04 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Amptiv Biosciences, Inc.
Free to see. No signup.
More on the people and the money behind Amptiv Biosciences, Inc., from the filings we hold.
Other Health Care raises by companies based in Ohio, filed within 90 days of this one, largest first.
Get an email when Amptiv Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Amptiv Biosciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Amptiv Biosciences, Inc. →Get the full cited report on Amptiv Biosciences, Inc.
What the filing shows about Amptiv Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Amptiv Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Amptiv Biosciences, Inc.'s address as 11000 Cedar Ave, Ste 21, Cleveland, OH 44106.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Amptiv Biosciences, Inc. See pricing
Amptiv Biosciences, Inc. is a registered filer with the SEC (CIK 2032327) and has filed since 2024-12-31. 2 filings are on record, the latest on 2025-04-04.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Amptiv Biosciences, Inc.'s Form D of 2025-04-04 names Jonathan Bell and Jon Armstrong as its officers, directors or promoters.
Its new offerings report $500K sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 863 filings in Other Health Care, totalled by week.
A portion of the proceeds may be used to pay salaries to executive officers in the ordinary course of business.
Jonathan Bell is named as Executive Officer and Director on the Form D that Amptiv Biosciences, Inc. filed with the SEC on 4 April 2025, one of 2 people that filing names.
Jon Armstrong is named as Director on the Form D that Amptiv Biosciences, Inc. filed with the SEC on 4 April 2025, one of 2 people that filing names.
2 people named on the filing — 1 holding an executive role and 1 as a director only.
Named as of the 2025-04-04 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Amptiv Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Amptiv Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Amptiv Biosciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Amptiv Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Amptiv Biosciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Amptiv Biosciences, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/amptiv-biosciences-inc-form-d-25000001